DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
ICON Collaborators.
Paclitaxel plus carboplatin versus standard chemotherapy with either
single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in
women with ovarian cancer: the ICON3 randomised trial.
Lancet 2002;
360: 505-515
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.